Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT: Prazosin for Combat Trauma PTSD
NCT00532493Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Prazosin Group with Placebo Group (2 arms). Primary endpoints: Clinician Administered PTSD Scale Recurrent Distressing Dreams Item at 10 weeks, Pittsburgh Sleep Quality Index at 10 weeks and 1 more. Started Jan 2010; status: completed.
02
Drugs
prazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00532493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532493.